163 related articles for article (PubMed ID: 35903204)
1. RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications.
Abdelbary AM; Kaf RM; Lashin ME; Alattar AZ; Elsayed DH; Amin AF; Gertallah LM; Yehia AM
Contemp Oncol (Pozn); 2022; 26(2):109-122. PubMed ID: 35903204
[TBL] [Abstract][Full Text] [Related]
2. ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.
Henry CE; Llamosas E; Daniels B; Coopes A; Tang K; Ford CE
Gynecol Oncol; 2018 Mar; 148(3):576-584. PubMed ID: 29395309
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the prognostic significance of receptor tyrosine kinase-like orphan receptor 1 (ROR1) in lung carcinoma and its relation to lymphangiogenesis and epithelial mesenchymal transition.
Heabah NAE; Darwish SA; Eid AM
Pathol Res Pract; 2023 Aug; 248():154703. PubMed ID: 37481855
[TBL] [Abstract][Full Text] [Related]
4. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
5. BMI‑1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor.
Yu J; Chen L; Bao Z; Liu Y; Liu G; Li F; Li L
Oncol Rep; 2020 May; 43(5):1630-1640. PubMed ID: 32323819
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinicopathological significance of TMEFF2, SMOC-2, and SOX17 expression in endometrial carcinoma.
Alabiad MA; Harb OA; Hefzi N; Ahmed RZ; Osman G; Shalaby AM; Alnemr AA; Saraya YS
Exp Mol Pathol; 2021 Oct; 122():104670. PubMed ID: 34339705
[TBL] [Abstract][Full Text] [Related]
7. ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target.
Liu D; Gunther K; Enriquez LA; Daniels B; O'Mara TA; Tang K; Spurdle AB; Ford CE
Sci Rep; 2020 Aug; 10(1):13906. PubMed ID: 32807831
[TBL] [Abstract][Full Text] [Related]
8. c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
Zhuang XP; Jin WW; Teng XD; Yuan ZZ; Lin QQ; Xu ST
Eur J Gynaecol Oncol; 2015; 36(3):255-9. PubMed ID: 26189249
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma.
Liu XR; Cai CX; Luo LM; Zheng WL; Shi R; Zeng J; Xu YQ; Wei M; Ma WL
Cancer Cell Int; 2016; 16():15. PubMed ID: 26933386
[TBL] [Abstract][Full Text] [Related]
10. Tumor expression of human growth hormone and human prolactin predict a worse survival outcome in patients with mammary or endometrial carcinoma.
Wu ZS; Yang K; Wan Y; Qian PX; Perry JK; Chiesa J; Mertani HC; Zhu T; Lobie PE
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1619-29. PubMed ID: 21849525
[TBL] [Abstract][Full Text] [Related]
11. Expression of the RON receptor tyrosine kinase and its association with gastric carcinoma versus normal gastric tissues.
Zhou D; Pan G; Zheng C; Zheng J; Yian L; Teng X
BMC Cancer; 2008 Nov; 8():353. PubMed ID: 19040718
[TBL] [Abstract][Full Text] [Related]
12. Analysis of recurrence and survival rates in grade 3 endometrioid endometrial carcinoma.
Wang J; Jia N; Li Q; Wang C; Tao X; Hua K; Feng W
Oncol Lett; 2016 Oct; 12(4):2860-2867. PubMed ID: 27698871
[TBL] [Abstract][Full Text] [Related]
13. Forkhead box M1 over-expression and dachshund homolog 1 down-regulation as novel biomarkers for progression of endometrial carcinoma in Egyptian patients.
Hafez AM; Harb OA; Etman WM; Hamed B; Namour AE; Abdelaziz LA
Contemp Oncol (Pozn); 2021; 25(2):107-117. PubMed ID: 34667437
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological roles of adiponectin and leptin receptors in endometrial carcinoma.
Yabushita H; Iwasaki K; Obayashi Y; Wakatsuki A
Oncol Lett; 2014 Apr; 7(4):1109-1117. PubMed ID: 24944677
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells.
Zhang S; Zeng N; Alowayed N; Singh Y; Cheng A; Lang F; Salker MS
PLoS One; 2017; 12(8):e0183681. PubMed ID: 28841682
[TBL] [Abstract][Full Text] [Related]
17. Clinical application of intratumoral blood flow study in patients with endometrial carcinoma.
Cheng WF; Chen TM; Chen CA; Wu CC; Huang KT; Hsieh CY; Hsieh FJ
Cancer; 1998 May; 82(10):1881-6. PubMed ID: 9587120
[TBL] [Abstract][Full Text] [Related]
18. Expression of ELF5 in endometrial carcinoma tissues and its clinical significance.
Yang H; Yan H
Oncol Lett; 2018 Sep; 16(3):3473-3480. PubMed ID: 30127951
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
20. The extent of cyclin D1 expression in endometrial pathologies and relevance of cyclin D1 with the clinicopathological features of endometrioid endometrial carcinoma.
Yildirim HT; Nergiz D; Sadullahoglu C; Akgunduz Z; Yildirim S; Dogan S; Sezer C
Indian J Pathol Microbiol; 2020; 63(3):412-417. PubMed ID: 32769330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
